TNF and tuberculosis: The inverse relationship between palmitoleic acid and TNF suggests a molecular mechanism that differs from that of direct TNF blockade, implying that symbiotic bacterial products may offer alternative and gentler therapeutics to deliver anti-TB benefits to patients.